期刊文献+

肿瘤社会属性探究 被引量:10

暂未订购
导出
摘要 肿瘤已不单是突变的癌细胞,更像一个多种细胞类型和成分组成的新器官,与其所处的微环境构成了一个复杂的社会。本文探讨肿瘤的多类型细胞构成的整体特征,同时分析肿瘤遗传、代谢、繁殖、进化和意识的生命特征。肿瘤社会性研究可能改变我们对肿瘤治疗的策略。
出处 《医学争鸣》 CAS 北大核心 2012年第6期16-17,20,共3页 Negative
基金 兰州军区"十二五"医学科技专项课题(2012-06)
关键词 肿瘤 微环境 社会
  • 相关文献

参考文献9

  • 1CAntles AJ, Gallahan D. Syste~ biology: confronting the complexity of cancer [J]. Cancer Res, 2011, 71(18):5961-5964.
  • 2Bissell M J, Labarge MA. Context, tissue plasticity, and cancer: are tumor stern cells also regulated by the microenvironment?[J]. Cancer Cell, 2005, 7(1):17-23.
  • 3Axelrod R, Axelrod DE, Pienta KJ. Evolution of cooperation among tumor cells [J]. Proc Natl Acad Sci USA, 2006, 103 (36):13474-13479.
  • 4张百红,王湘辉.肿瘤微环境中的起始细胞[J].现代肿瘤医学,2011,19(6):1245-1246. 被引量:5
  • 5Campbell PJ. Telomeres and cancer: from crisis to stability to crisis to stability [J]. Cell, 2012, 148(4):633-635.
  • 6樊代明.浅议肿瘤本质[J].医学争鸣,2011,2(5):3-5. 被引量:14
  • 7樊代明.再议肿瘤本质[J].医学争鸣,2011,2(6):3-5. 被引量:8
  • 8Kareva I. What can ecology teach us about cancer? [J] Transl Oncol, 2011, 4(5):266-270.
  • 9Reichle A, Vogt T. Systems biology: a therapeutic target for tumor therapy [J]. Cancer Microenviron, 2008, 1(1):159-170.

二级参考文献30

  • 1郝书辰.从感悟牛津看向世界一流大学学什么?[J].中国高等教育,2006(20):27-29. 被引量:8
  • 2Parrinello S, Lloyd AC. Neurofibroma development in NF1 - - insights into tumour initiation[ J]. Trends Cell Biol, 2009,19 ( 8 ) : 395 - 403.
  • 3Alkatout I, Kabelitz D, Kalthoff H, et al. Prowling wolves in sheep's clothing: the search for tumor stem cells [ J]. Biol Chem, 2008,389 ( 7 ) : 799 - 811.
  • 4Morris ZS, MeClatchey AI. The neurofibroma cell of origin: SKPs expand the playing field[J]. Cell Stem Cell ,2009,4 (5) :371 - 372.
  • 5Le LQ, Shipman T, Burns DK, et al. Cell of origin and microenvironment contribution for NF1 - associated dermal neurofibromas [J]. Cell Stem Cell,2009,4(5) :453 -463.
  • 6Mishra PJ, Mishra PJ, Glod JW, et al. Mesenchymal stem ceils: flip side of the coin[J]. Cancer Res,2009,69(4) :1255 -1258.
  • 7Gilbertson R J, Gutmann DH. Tumorigenesis in the brain: location, location, location [ J]. Cancer Res,2007,67 ( 12 ) : 5579 - 5582.
  • 8Ding YT, Kumar S, Yu DC. The role of endothelial progenitor cells in tumour vasctdogenesis [ J ]. Pathobiology, 2008,75 (5) : 265 - 273.
  • 9Gao JX. Cancer stem cells : the lessons from pre - cancerous stem cells [ J ]. J Cell Mol Med,2008,12 ( 1 ) : 67 - 96.
  • 10Jandial R, Levy ML, Snyder EY. Brain tumor stem cells and the tumor microenvironment [ J]. Neurosurg Focus,2008,24 (3 - 4 ) : E27.

共引文献19

同被引文献174

  • 1刘娇萍,袁昌劲,曹继刚,邹小娟,卢威,刘礼.从“象思维”探讨对肿瘤微环境的中医认识[J].时珍国医国药,2018,29(11):2723-2725. 被引量:23
  • 2林小力,谭炜焓,朱风旖,梁丹,严然,由凤鸣.基于“左血右气”论左右半结肠癌变病机偏侧性[J].北京中医药大学学报,2020(5):432-435. 被引量:4
  • 3徐振晔,郑展.中医药分阶段防治恶性肿瘤术后复发转移优化方案探讨[J].中西医结合学报,2007,5(1):5-10. 被引量:50
  • 4MAITLAND M L, SCHILSKY R L. Clinical trials in the era of personalized oncology[J]. CA Cancer J Clin, 2011, 61 (6):365-3+81.
  • 5ALLEGRA C, SARGENT D J. Adjuvant therapy for colon cancer-the pace quickens[J]. N Engl J Med, 2005, 352(26):2746-2748.
  • 6ANDRE N, PASQUIER E. For cancer, seek and destroy or live and let live?[J] Nature, 2009, 460(7253):324.
  • 7GATENBY R A. A change of strategy in the war on cancer[J]. Nature, 2009, 459(7246):508-5090.
  • 8HAYDEN E C. Personalized cancer therapy gets closer[J]. Nature, 2009, 458(7235): 131-132.
  • 9BOKEMEYER C, BONDARENKO I, HARTMANN J T, et al. Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS studv[J]. Ann Oneal, 2011,22(7):1535-1546.
  • 10LAZAR A A, COLE B F, BONETTI M, et al. Evaluation of treatment-effect heterogeneity using biomarkers measured on a continuous scale: subpopulation treatment effect pattern plot[J]. J Clin Oncol, 2010, 28(29):4539-4544.

引证文献10

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部